Patient safety
starts online.
One in ten medicines in low- and middle-income countries is falsified. The new battleground is digital — illegal pharmacies, social-media GLP-1s, counterfeit oncology drugs.
1 in 10
Medicines in LMICs falsified
$200B
Annual revenue lost
35K+
Rogue pharmacies tracked
FDA
OCI coordinated takedowns
// THREAT VECTORS
Counterfeit pharma in the digital age.
GLP-1 & Injectable Fakes
Compounded or counterfeit semaglutide, tirzepatide and HGH sold openly on social and Telegram. Life-threatening dosage errors.
Illegal Online Pharmacies
Rogue pharmacies dispensing controlled substances without prescription — often clones of legitimate brand sites.
Cloned Packaging & Lot Codes
Replicated serialization and 2D-DataMatrix codes that defeat pharmacist verification at the counter.
// PROTECTION PROTOCOL
GxP-grade enforcement.
Regulator-ready evidence.
Lab-verified test buys, accredited toxicology partners, court-admissible chain of custody. Direct relationships with INTERPOL, FDA OCI and EU authorities.
Protect your patients.
Protect your pipeline.
Confidential threat assessment for any of your top molecules. NDA-backed, regulator-aware, GxP-aligned.